OGN SEC Filings: 8-K, 10-Q, S-3 & 424B – Organon &

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Oct 30, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Jul 31, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 4, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 24, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 10, 2025

10-Q/A

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

Nov 10, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Organon & Co. Reports Q3 2026 Supplemental Financial Information and Non-GAAP Reconciliations

Oct 30, 2026

8-K

Organon & Co. Reports Supplemental Non-GAAP Financial Information for Q2 2026

Jul 31, 2026

8-K

Organon & Co. Stockholders Approve Merger Agreement with Sun Pharmaceutical Holdings USA, Inc.

Jul 23, 2026

8-K

Organon & Co. Files Supplemental Proxy Disclosures Amid Merger Litigation

Jul 17, 2026

8-K

Organon & Co. Announces Results of 2026 Annual Meeting of Stockholders

Jun 11, 2026

8-K

Organon Reports Q1 2026 Financial Results and Pending Merger with Sun Pharma

Apr 30, 2026

Prospectus

TYPE

HEADLINE

FILED AT

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 13, 2025

S-8

Registration

Jun 3, 2021

10-12B/A

Common Stock, par value $0.01 per share

Apr 29, 2021

10-12B/A

Common Stock, par value $0.01 per share

Apr 14, 2021

10-12B

Common Stock, par value $0.01 per share

Mar 17, 2021

DRS/A

Form DRS/A - Draft Registration Statement: [Amend]

Dec 21, 2020

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Jul 17, 2026

DEFM14A

Form DEFM14A - Definitive proxy statement relating to merger or acquisition

Jun 17, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Jun 11, 2026

PREM14A

Form PREM14A - Preliminary proxy statements relating to merger or acquisition

Jun 1, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 30, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 30, 2026

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

Pentwater Capital Management LP (Filed by)

Aug 14, 2026

Arjona Ferreira Juan Camilo (Reporting)

Aug 12, 2026

144

Form 144 - Report of proposed sale of securities

Aug 5, 2026

Drinane Juliana Papa (Reporting)

Aug 5, 2026

SCHEDULE 13G/A

VANGUARD PORTFOLIO MANAGEMENT LLC (Filed by)

Jul 31, 2026

Sharp Shalini (Reporting)

Jun 15, 2026

Other

TYPE

HEADLINE

FILED AT

Form SD - Specialized disclosure report

May 29, 2026

Form SD - Specialized disclosure report

Jun 2, 2025

LETTER

Form UPLOAD - SEC-generated letter

Jun 25, 2024

CORRESP

Form CORRESP - Correspondence

Jun 6, 2024

Form SD - Specialized disclosure report

May 28, 2024

LETTER

Form UPLOAD - SEC-generated letter

May 23, 2024

Organon & Co. OGN · SEC Filings